[1]耿琦,丛军.肠吉泰对肠易激综合征内脏高敏感大鼠PAR2、PKCε、TRPV1蛋白表达的影响[J].西部中医药,2022,35(04):60-63.[doi:10.12174/j.issn.2096-9600.2022.04.13]
　GENG Qi,CONG Jun.Effects of Changjitai Decoction on the Expressions of PAR2, PKCε and TRPV1 Protein in Visceral Hypersensitivity Rats with Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2022,35(04):60-63.[doi:10.12174/j.issn.2096-9600.2022.04.13]
点击复制

肠吉泰对肠易激综合征内脏高敏感大鼠PAR2、PKCε、TRPV1蛋白表达的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年04期
页码:
60-63
栏目:
出版日期:
2022-04-15

文章信息/Info

Title:
Effects of Changjitai Decoction on the Expressions of PAR2, PKCε and TRPV1 Protein in Visceral Hypersensitivity Rats with Irritable Bowel Syndrome
作者:
耿琦, 丛军
上海中医药大学附属曙光医院，上海 200021
Author(s):
GENG Qi, CONG Jun
Shuguang Hospital Affiliated to Shanghai University of TCM, Shanghai 200021, China
关键词:
肠易激综合征; 肠吉泰; 内脏高敏感; PAR2; PKCε; TRPV1; 动物实验
Keywords:
irritable bowel syndrome; decoction; visceral hypersensitivity; PAR2; PKCε; TRPV1; zoopery
分类号:
R975
DOI:
10.12174/j.issn.2096-9600.2022.04.13
文献标志码:
A
摘要:
目的探讨肠吉泰对内脏高敏感模型大鼠的调节作用。 方法选择新生SD大鼠40只，按照随机数字表法随机分为空白组、模型对照组、阳性对照组及肠吉泰组，每组10只。参照Alchaer直肠醋酸刺激法建立IBS内脏高敏感大鼠模型。造模期间阳性对照组大鼠给予腹腔注射Capsazepine，其余各组除空白组外均给予相同体积的溶剂腹腔注射。从第8周开始，肠吉泰组每日给予0.423 g/mL的剂量中药灌胃，空白组、模型对照组和阳性对照组每日予以等量去离子水灌胃，各组均持续灌胃4周。干预4周后，采用结直肠气囊扩张法测定并记录大鼠腹壁反射（abdominal withdrawal reflex，AWR）评分，进行肠道敏感性评估；使用Western blot法检测大鼠结肠黏膜组织蛋白酶激活受体2（proteinase-activated receptors 2，PAR2）、下游物质蛋白激酶Cε（protein kinaseCε，PKCε）、瞬时感受器电位香草酸受体1（transient receptor potential vanilloid1，TRPV1）、磷酸化TRPV1（p-TRPV1）的表达。 结果当气囊压力为40、60 mm Hg（1 mm Hg≈0.133 kPa）时，模型对照组大鼠AWR评分较空白组明显升高（P＜0.01）；肠吉泰组和阳性对照组AWR评分与模型组比较均明显降低（P＜0.05）。与模型对照组比较，阳性对照组及肠吉泰组PAR2、PKCε、TRPV1、p-TRPV1的表达显著降低（P＜0.05）。 结论肠吉泰可能是通过下调PAR2、PKCε、TRPV1、p-TRPV1的表达，抑制其活化，从而改善IBS内脏高敏感。
Abstract:
ObjectiveTo discuss the regulatory effect of Changjitai decoction on rat model with visceral hypersensitivity. MethodsForty newborn SD rats were selected, divided into the blank group, model control group, positive control group and Changjitai decoction group according to random number table method, ten rats in each group, visceral hypersensitive rat model with IBS was established by referring to Alchaer rectal acetic acid stimulation. During the modeling period, rats in the positive control group were intraperitoneally injected with Capsazepine, and all other groups were intraperitoneally injected with the same volume of solvent except the blank group. From the 8th week, Changjitai decoction group was drenched with a dose of 0.423g/mL of herbs each day, the blank group, model control group and positive control group with the equivalent deionized water each day, different groups were medicated for four weeks consecutively by irrigation. After intervention for four weeks, colorectal balloon dilation was used to detect and record AWR scores of the rats, and to perform intestinal sensitivity; Western blot method was applied to detect the expressions of PAR2, PKCε, TRPV1 and p-TRPV1 in colonic mucosa of the rats. ResultsWhen the balloon pressure was 40 and 60 mm Hg(1 mm Hg≈0.133 kPa), AWR scores of model control group increased notably compared with these of the blank group (P<0.01); AWR scores decreased obviously in Changjitai decoction group and positive control group compared with the model group (P<0.05). Compared with model control group, the expressions of PAR2, PKCε, TRPV1 and p-TRPV1 reduced notably in positive control group and Changjitai decoction group (P<0.05). ConclusionChangjitai decoction could inhibit the activation of PAR2, PKCε, TRPV1 and p-TRPV1 possibly through down regulating their expressions, thus improving visceral hypersensitivity in IBS patients.

相似文献/References:

[1]信 楠,杨培培 指导：沈舒文.健脾导滞汤治疗肠易激综合征30例[J].西部中医药,2012,25(10):91.
　XIN Nan,YANG Pei-pei Director: SHEN Shu-wen.JianPi DaoZhiTang in Treating 30 Cases of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(04):91.
[2]周荣,彭琪,张敏.人参败毒散加味治疗腹泻型肠易激综合征 54 例[J].西部中医药,2014,27(08):52.
[3]牛立军,苏强,刘振伟,等.安肠止痛组方联合曲美布汀治疗腹泻型肠易激综合征 78 例[J].西部中医药,2014,27(08):81.
[4]张丽娜,刘则鹏,廖志峰.泻肝健脾补肾汤治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2014,27(09):120.
[5]张晓宁,马玉侠.隔药灸脐与匹维溴铵对脾虚型肠易激综合征患者尿液代谢组学影响的异同[J].西部中医药,2015,28(07):1.
[6]寇媛,赵倩,闻新丽,等.中医三联疗法治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2015,28(11):79.
[7]杨磊,孙洁,李滢,等.电针对IBS模型大鼠肠系膜微血管管径与血浆CGRP、VIP水平的影响*[J].西部中医药,2014,27(03):22.
　YANG Lei,SUN Jie,LI Ying,et al.Influence of Acusector on the Levels of CGRP and VIP in the Plasma and Mesenteric Microvascular Caliber of IBS Rat Model[J].Western Journal of Traditional Chinese Medicine,2014,27(04):22.
[8]梁胜斌,杨世洁,李共信,等.敦煌葆元汤治疗肝郁脾虚型肠易激综合征的临床观察[J].西部中医药,2013,26(07):79.
　LIANG Shengbin,YANG Shijie,LI Gongxin,et al.Clinical Observation on DunHuang BaoYuanTang in Treating Irrirable Bowel Syndrome of Liver Qi Stagnation and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):79.
[9]诸凡凡,叶 柏△.腹泻型肠易激综合征发病机制及治疗现状[J].西部中医药,2013,26(10):139.
　ZHU Fanfan,YE Bai.Current State of the Treatment and Pathogenesis of Diarrhea Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(04):139.
[10]曹俊,赵智强△.赵智强教授辨治腹泻型肠易激综合征经验介绍[J].西部中医药,2018,31(04):56.
　CAO Jun,ZHAO Zhiqiang.Professor Zhao Zhiqiang′s Experience of Differentiating and Treating Diarrhea-type Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(04):56.

备注/Memo

备注/Memo:
耿琦（1988—），女，主治医师，博士学位。研究方向：消化系统疾病的中医临床评价及实验研究。国家自然科学基金青年基金（81202661）；蔡淦全国名中医传承工作室（MZYGZS-2017003）。
更新日期/Last Update: 2022-06-24